SCHEMBL39310

SCHEMBL39310

CC(C)(C)OC(=O)c1ccccc1O

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.62
TSHR P16473 2/20 0.62
HPGD P15428 7/20 0.53
HSD17B10 Q99714 4/20 0.53
ALOX15 P16050 2/20 0.53
TDP1 Q9NUW8 2/20 0.52
ALDH1A1 P00352 6/20 0.49
KDM4E B2RXH2 5/20 0.49
SMN1; SMN2 Q16637 2/20 0.48
CA12 O43570 1/20 0.48
CA1 P00915 1/20 0.48
CA2 P00918 1/20 0.48
HMGB1 P09429 1/20 0.48
CA4 P22748 1/20 0.48
CA6 P23280 1/20 0.48
CA7 P43166 1/20 0.48
CA9 Q16790 1/20 0.48
NAPRT Q6XQN6 1/20 0.48
CA14 Q9ULX7 1/20 0.48
ADRB2 P07550 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29701290 1.00 LMNA (0.62) LMNATSHRHPGDHSD17B10ALOX15
Bromide SCHEMBL6849788 0.98 LMNA (0.60) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL5033583 0.98 LMNA (0.60) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL31134837 0.98 LMNA (0.60) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL3418963 0.98 LMNA (0.60) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL14236815 0.98 LMNA (0.60) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL10353738 0.98 LMNA (0.60) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL1782675 0.98 LMNA (0.60) LMNATSHRHPGDHSD17B10ALOX15
SCHEMBL28737706 0.98 LMNA (0.60) LMNATSHRHPGDHSD17B10ALOX15
Lithium SCHEMBL14236817 0.98 LMNA (0.60) LMNATSHRHPGDHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 429 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119385875-A Oil-in-water lip glaze and preparation method thereof 上海臻臣化妆品有限公司 2025-02-07 CN claimed
CN-119286488-A Non-acidic unblocking liquid system for unblocking oil and gas well and preparation method thereof 中石化石油工程技术服务股份有限公司 2025-01-10 CN claimed
CN-117721643-A Graphene fiber heat insulation grid cloth and preparation method thereof 江西甬宜新材料有限公司 2024-03-19 CN claimed
CN-117103823-A Antistatic plastic-coated fabric and preparation method thereof 杭州永前布业有限公司 2023-11-24 CN claimed
CN-114806189-A Environment-friendly asphalt biological regenerant and preparation method thereof 湖北工业大学 2022-07-29 CN claimed
CN-107200981-B A kind of antiultraviolet plastic matrix and preparation method 浙江乍浦塑料制品有限公司 2019-06-11 CN claimed
EP-2773729-B1 THE USE OF QUATERNIZED POLYETHERAMINES AS ADDITIVES IN FUELS AND LUBRICANTS BASF SE (DE) 2019-02-13 EP claimed
CN-208471914-U A kind of new-energy automobile glass 卢洪言 2019-02-05 CN claimed
CN-107325601-A A kind of water-repellent modified coating of UV resistant 天长市巨龙车船涂料有限公司 2017-11-07 CN claimed
CN-107200981-A A kind of antiultraviolet plastic matrix and preparation method 成都新柯力化工科技有限公司 2017-09-26 CN claimed
CN-106517810-A High-safety ultraviolet-proof automotive glass and preparation method thereof 重庆动沃机车产业有限公司 2017-03-22 CN claimed
CN-106336125-A Automotive glass 重庆东科模具制造有限公司 2017-01-18 CN claimed
CN-103429428-B Laminate for protecting metals from corrosive gases NORTHERN TECHNOLOGIES INTERNATIONAL CORP. (US) 2016-04-27 CN claimed
CN-105399338-A High-strength ultraviolet-proof automotive glass and preparation method thereof CHEN GUIXING 2016-03-16 CN claimed
US-20150252277-A1 QUATERNIZED POLYETHER AMINES AND THEIR USE AS ADDITIVE FOR FUELS AND LUBRICANTS BASF SE (DE) 2015-09-10 US claimed
US-20110177454-A1 RESIST MATERIAL AND PATTERN FORMATION METHOD USING THE RESIST MATERIAL PANASONIC CORPORATION (JP) 2011-07-21 US claimed
EP-1490469-A2 METHODS AND COMPOSITIONS FOR REMOVING RESIDUES AND SUBSTANCES FROM SUBSTRATES USING ENVIRONMENTALLY FRIENDLY SOLVENTS North Carolina State University (US) 2004-12-29 EP claimed
US-20030213747-A1 Methods and compositions for removing residues and substances from substrates using environmentally friendly solvents NORTH CAROLINA STATE UNIVERSITY 2003-11-20 US claimed
WO-2003072215-A2 METHODS AND COMPOSITIONS FOR REMOVING RESIDUES AND SUBSTANCES FROM SUBSTRATES USING ENVIRONMENTALLY FRIENDLY SOLVENTS NORTH CAROLINA STATE UNIVERSITY (US) 2003-09-04 WO claimed
US-12600116-B2 Special polymer layers for faster laminability of multilayer structures COVESTRO DEUTSCHLAND AG (DE) 2026-04-14 US disclosed
US-12440466-B2 Fatty acid derivatives for treating non-alcoholic steatohepatitis BASF AS (NO) 2025-10-14 US disclosed
US-12365775-B2 Process for partial colouring of plastic parts using solid colourants in colour- carrier layers COVESTRO DEUTSCHLAND AG (DE) 2025-07-22 US disclosed
US-20250205963-A1 METHOD FOR PRODUCING A PLASTIC MOLDING tooz technologies GmbH (DE) 2025-06-26 US disclosed
EP-4549163-A2 IMPROVED METHOD FOR PARTIAL COLOURING OF PLASTIC PARTS Covestro Deutschland AG (DE) 2025-05-07 EP disclosed
US-20250091332-A1 FILM STRUCTURE SUITABLE FOR RAPID LAMINATION COVESTRO DEUTSCHLAND AG (DE) 2025-03-20 US disclosed
CN-118782313-B Super-large current load's wear-resisting liquid cooling cable for new forms of energy 安徽远征传导科技股份有限公司 2025-02-25 CN disclosed
EP-3840958-B1 IMPROVED METHOD FOR PARTIAL COLOURING OF PLASTIC PARTS COVESTRO DEUTSCHLAND AG (DE) 2025-02-19 EP disclosed
CN-119385875-A Oil-in-water lip glaze and preparation method thereof 上海臻臣化妆品有限公司 2025-02-07 CN disclosed
US-12195602-B2 Plastic films having high Vicat softening temperature in layered structures COVESTRO DEUTSCHLAND AG (DE) 2025-01-14 US disclosed
CN-119286488-A Non-acidic unblocking liquid system for unblocking oil and gas well and preparation method thereof 中石化石油工程技术服务股份有限公司 2025-01-10 CN disclosed
CN-119220320-A Stainless steel cold rolling liquid composition and preparation method and application thereof 中国石油化工股份有限公司 2024-12-31 CN disclosed
EP-3720431-B1 FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS BASF AS (NO) 2024-10-30 EP disclosed
CN-118782313-A Super-large current load's wear-resisting liquid cooling cable for new forms of energy 安徽远征传导科技股份有限公司 2024-10-15 CN disclosed
US-12115178-B2 Acylated active agents and methods of their use for the treatment of autoimmune disorders FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2024-10-15 US disclosed
CN-118695935-A Method for producing polymer molded parts 图茨技术股份有限公司 2024-09-24 CN disclosed
EP-3890971-B1 PLASTIC FILMS WITH HIGH VICAT SOFTENING POINT IN COATING STRUCTURES COVESTRO DEUTSCHLAND AG (DE) 2024-08-28 EP disclosed
EP-3634430-B1 MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V INC (US) 2024-08-07 EP disclosed
CN-118401370-A At least partially bio-based layered structure with good advantageous properties 科思创德国股份有限公司 2024-07-26 CN disclosed
US-12023953-B2 Layer structure with modified structure, and production thereof COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2024-07-02 US disclosed
US-20240209169-A1 PROCESS FOR PARTIAL COLOURING OF PLASTIC PARTS USING SOLID COLOURANTS IN COLOUR-CARRIER LAYERS COVESTRO DEUTSCHLAND AG (DE) 2024-06-27 US disclosed
US-20240180941-A1 ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE FLAGSHIP PIONEERING INNOVATIONS V INC (US) 2024-06-06 US disclosed
CN-114650915-B Layer structure with modified structure and production thereof 科思创德国股份有限公司 2024-05-31 CN disclosed
EP-4370334-A1 FILM STRUCTURE SUITABLE FOR RAPID LAMINATION Covestro Deutschland AG (DE) 2024-05-22 EP disclosed
EP-4370333-A1 SPECIAL POLYMER LAYERS FOR FASTER LAMINABILITY OF MULTILAYER STRUCTURES Covestro Deutschland AG (DE) 2024-05-22 EP disclosed
CN-118048732-A High-elasticity spun-bonded non-woven fabric and preparation method thereof 黄河三角洲京博化工研究院有限公司 2024-05-17 CN disclosed
US-20240156769-A1 FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS BASF AS (NO) 2024-05-16 US disclosed
US-11976083-B2 Inhibitors of peptidylarginine deiminases GILEAD SCIENCES, INC. (US) 2024-05-07 US disclosed
CN-117950267-A Photosensitive resin composition, photosensitive dry film and PCB printed circuit board 杭州福斯特电子材料有限公司 2024-04-30 CN disclosed
CN-115551862-B Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2024-04-12 CN disclosed
EP-4016180-B1 DISPLAY PANEL STRUCTURE AND DRIVING METHOD THEREFOR NSPECTRA CO LTD (KR) 2024-03-20 EP disclosed
CN-117721643-A Graphene fiber heat insulation grid cloth and preparation method thereof 江西甬宜新材料有限公司 2024-03-19 CN disclosed
US-11925614-B2 Fatty acid derivatives for treating non-alcoholic steatohepatitis BASF AS (NO) 2024-03-12 US disclosed
CN-117677499-A Specific polymer layers useful for faster lamination of multilayer structures 科思创德国股份有限公司 2024-03-08 CN disclosed
CN-117642290-A Film structure suitable for rapid lamination 科思创德国股份有限公司 2024-03-01 CN disclosed
WO-2024041586-A1 PRODRUG OF JAK KINASE INHIBITOR 启元生物(杭州)有限公司 2024-02-29 WO disclosed
EP-4323195-A1 PROCESS FOR PARTIAL COLOURING OF PLASTIC PARTS USING SOLID COLOURANTS IN COLOUR-CARRIER LAYERS Covestro Deutschland AG (DE) 2024-02-21 EP disclosed
CN-117203063-A Method for locally coloring plastic parts using solid dyes in a color carrier layer 科思创德国股份有限公司 2023-12-08 CN disclosed
CN-117103823-A Antistatic plastic-coated fabric and preparation method thereof 杭州永前布业有限公司 2023-11-24 CN disclosed
US-11813272-B2 Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2023-11-14 US disclosed
US-11813272-B2 Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2023-11-14 US disclosed
US-11813272-B2 Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2023-11-14 US disclosed
CN-113226757-B Plastic film in the form of a layer structure with a high Vicat softening temperature 科思创知识产权两合公司 2023-10-24 CN disclosed
US-20230293458-A1 MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V INC (US) 2023-09-21 US disclosed
CN-111542565-B Plastic film with reduced UV activity 科思创德国股份有限公司 2023-08-22 CN disclosed
US-11731411-B2 Plastic films for ID documents with better lightness of embossed holograms COVESTRO DEUTSCHLAND AG (DE) 2023-08-22 US disclosed
EP-4219667-A2 USE OF QUATERNISED ALKYLAMINE AS ADDITIVES IN FUELS AND LUBRICANTS BASF SE (DE) 2023-08-02 EP disclosed
CN-116406364-A Tetrahydroisoquinoline derivatives for the treatment of erythrocyte disorders and inflammatory diseases 赛诺菲公司 2023-07-07 CN disclosed
EP-2791291-B1 USE OF QUATERNISED ALKYLAMINE AS ADDITIVE IN FUELS AND LUBRICANTS BASF SE (DE) 2023-04-26 EP disclosed
CN-110088175-B Plastic film for ID documents with improved laser engraving capability and improved chemical resistance 科思创德国股份有限公司 2023-03-31 CN disclosed
EP-4143189-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2023-03-08 EP disclosed
WO-2023285358-A1 FILM STRUCTURE SUITABLE FOR RAPID LAMINATION COVESTRO DEUTSCHLAND AG (DE) 2023-01-19 WO disclosed
WO-2023285356-A1 SPECIAL POLYMER LAYERS FOR FASTER LAMINABILITY OF MULTILAYER STRUCTURES COVESTRO DEUTSCHLAND AG (DE) 2023-01-19 WO disclosed
US-20230008490-A1 LAYER STRUCTURE WITH MODIFIED STRUCTURE, AND PRODUCTION THEREOF COVESTRO DEUTSCHLAND AG (DE) 2023-01-12 US disclosed
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed
US-20230002553-A1 FILMS HAVING SPECIAL PROPERTIES COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2023-01-05 US disclosed
CN-115551862-A Macrocyclic inhibitors of peptidyl arginine deiminase 吉利德科学公司 2022-12-30 CN disclosed
WO-2022263244-A1 QUATERNIZED BETAINES AS ADDITIVES IN FUELS BASF SE (DE) 2022-12-22 WO disclosed
CN-112654508-B Improved method for locally coloring plastic parts 科思创知识产权两合公司 2022-11-08 CN disclosed
WO-2022218900-A1 PROCESS FOR PARTIAL COLOURING OF PLASTIC PARTS USING SOLID COLOURANTS IN COLOUR-CARRIER LAYERS COVESTRO DEUTSCHLAND AG (DE) 2022-10-20 WO disclosed
EP-4073151-A1 FILMS HAVING SPECIAL PROPERTIES Covestro Intellectual Property GmbH & Co. KG (DE) 2022-10-19 EP disclosed
US-20220276543-A1 DISPLAY PANEL STRUCTURE AND DRIVING METHOD THEREFOR NSPECTRA CO., LTD (KR) 2022-09-01 US disclosed
EP-3247734-B1 PREPARATION OF HIGHLY HEAT-RESISTANT (EO)POIYCARBONATES BY THE TRANSESTERIFICATION METHOD COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-08-31 EP disclosed
CN-114901652-A Substituted saturated and unsaturated N-heterocyclic carboxamides and related compounds for the treatment of medical disorders 比亚尔R&D投资股份公司 2022-08-12 CN disclosed
US-20220241814-A1 METHOD FOR THE PARTIAL COLORING OF PLASTIC PARTS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-08-04 US disclosed
CN-114806189-A Environment-friendly asphalt biological regenerant and preparation method thereof 湖北工业大学 2022-07-29 CN disclosed
CN-114746488-A Films with special properties 科思创知识产权两合公司 2022-07-12 CN disclosed
EP-4016180-A1 DISPLAY PANEL STRUCTURE AND DRIVING METHOD THEREFOR NSpectra Co., Ltd. (KR) 2022-06-22 EP disclosed
CN-114650915-A Layer structure with modified structure and production thereof 科思创知识产权两合公司 2022-06-21 CN disclosed
CN-114503026-A Display panel structure and driving method thereof 奈斯派克特株式会社 2022-05-13 CN disclosed
US-11311904-B2 Method for the partial coloring of plastic parts COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2022-04-26 US disclosed
US-20220110960-A1 ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS FLAGSHIP PIONEERING INNOVATIONS V, INC. 2022-04-14 US disclosed
US-20220110960-A1 ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS FLAGSHIP PIONEERING INNOVATIONS V, INC. 2022-04-14 US disclosed
US-11242464-B2 Method for the partial colouring of plastic parts COVESTRO DEUTSCHLAND AG (DE) 2022-02-08 US disclosed
CN-109568166-B Fragrance materials 宝洁公司 2022-01-28 CN disclosed
CN-108778766-B Method for partially dyeing plastic parts 科思创德国股份有限公司 2021-12-31 CN disclosed
US-20210403661-A1 PLASTIC FILMS HAVING HIGH VICAT SOFTENING TEMPERATURE IN LAYERED STRUCTURES COVESTRO DEUTSCHLAND AG (DE) 2021-12-30 US disclosed
US-20210394485-A1 PLASTIC FILMS HAVING HIGH OPACITY AND LOW TRANSPARENCY FOR ID DOCUMENTS HAVING A TRANSPARENT WINDOW COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2021-12-23 US disclosed
US-20210371609-A1 PLASTIC FILMS WITH REDUCED UV ACTIVITY COVESTRO LLC 2021-12-02 US disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 WO disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 WO disclosed
US-20210339508-A1 METHOD FOR MANUFACTURING A LAMINATE WHICH COMPRISES ELECTRONIC COMPONENTS AND/OR FUNCTIONAL UNITS COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2021-11-04 US disclosed
EP-3707198-B1 PLASTIC FILMS WITH REDUCED UV ACTIVITY COVESTRO DEUTSCHLAND AG (DE) 2021-10-27 EP disclosed
CN-108290820-B Method for recovering aromatic alcohol from melt polymerization and system for recovering same 沙特基础工业全球技术有限公司 2021-10-01 CN disclosed
US-20210283157-A1 ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS SENDA BIOSCIENCES, INC. 2021-09-16 US disclosed
US-20210283157-A1 ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS SENDA BIOSCIENCES, INC. 2021-09-16 US disclosed
CN-113242795-A Plastic film with high opacity and low transparency for identification documents with transparent window 科思创知识产权两合公司 2021-08-10 CN disclosed
CN-113226757-A Plastic film having a high Vicat softening temperature in the form of a layer structure 科思创知识产权两合公司 2021-08-06 CN disclosed
EP-3849794-A1 METHOD FOR MANUFACTURING A LAMINATE WHICH COMPRISES ELECTRONIC COMPONENTS AND/OR FUNTIONAL UNITS Covestro Intellectual Property GmbH & Co. KG (DE) 2021-07-21 EP disclosed
US-11058698-B2 Acylated active agents and methods of their use for the treatment of autoimmune disorders FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2021-07-13 US disclosed
US-11058698-B2 Acylated active agents and methods of their use for the treatment of autoimmune disorders FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2021-07-13 US disclosed
EP-3840958-A1 IMPROVED METHOD FOR THE PARTIAL COLORING OF PLASTIC PARTS Covestro Intellectual Property GmbH & Co. KG (DE) 2021-06-30 EP disclosed
CN-113056369-A Method for producing a laminate comprising electronic components and/or functional units 科思创知识产权两合公司 2021-06-29 CN disclosed
US-20210177877-A1 ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2021-06-17 US disclosed
US-20210179533-A1 SALICYL FUMARATE DERIVATIVE AND ITS APPLICATION IN THE TREATMENT OF PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES CHONGQING NEUROPARK BIOSCIENCE CO., LTD. (CN) 2021-06-17 US disclosed
US-20210177794-A1 FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS BASF AS (NO) 2021-06-17 US disclosed
WO-2021116356-A1 FILMS HAVING SPECIAL PROPERTIES COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) 2021-06-17 WO disclosed
US-20210177877-A1 ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2021-06-17 US disclosed
US-20210170441-A1 IMPROVED METHOD FOR THE PARTIAL COLORING OF PLASTIC PARTS COVESTRO DEUTSCHLAND AG (DE) 2021-06-10 US disclosed
US-20210147697-A1 IMPROVED METHOD FOR THE PARTIAL COLOURING OF PLASTIC PARTS COVESTRO DEUTSCHLAND AG (DE) 2021-05-20 US disclosed
EP-3801496-A1 ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE Flagship Pioneering Innovations V, Inc. (US) 2021-04-14 EP disclosed
EP-3801489-A1 ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS Flagship Pioneering Innovations V, Inc. (US) 2021-04-14 EP disclosed
CN-112654508-A Improved method for locally coloring plastic parts 科思创知识产权两合公司 2021-04-13 CN disclosed
US-10953027-B2 Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2021-03-23 US disclosed
US-10953027-B2 Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2021-03-23 US disclosed
US-20210063906-A1 LIQUID DEVELOPER CANON KK (JP) 2021-03-04 US disclosed
CN-112367987-A Active agents and methods for their use in treating metabolic disorders and non-alcoholic fatty liver disease 旗舰创业创新五公司 2021-02-12 CN disclosed
US-20210001614-A1 PLASTIC FILMS FOR ID DOCUMENTS WITH BETTER LIGHTNESS OF EMBOSSED HOLOGRAMS COVESTRO DEUTSCHLAND AG (DE) 2021-01-07 US disclosed
US-20200387110-A1 ADHESIVE-FREE PHOTOPOLYMER LAYER STRUCTURE COVESTRO DEUTSCHLAND AG (DE) 2020-12-10 US disclosed
EP-3721292-A1 ADHESIVE-FREE PHOTOPOLYMER LAYER STRUCTURE Covestro Deutschland AG (DE) 2020-10-14 EP disclosed
EP-3720431-A1 FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS BASF AS (NO) 2020-10-14 EP disclosed
CN-111712240-A Fatty acid derivatives for the treatment of non-alcoholic steatohepatitis 巴斯夫股份公司 2020-09-25 CN disclosed
CN-111542565-A Plastic film with reduced UV activity 科思创德国股份有限公司 2020-08-14 CN disclosed
CN-111479692-A Plastic film for identification documents with better brightness of the embossed hologram 科思创德国股份有限公司 2020-07-31 CN disclosed
CN-111479804-A Method for producing modulators of cystic fibrosis transmembrane conductance regulator 弗特克斯药品有限公司 2020-07-31 CN disclosed
CN-111465898-A Adhesive-free photopolymer layer construction 科思创德国股份有限公司 2020-07-28 CN disclosed
US-20200197428-A1 ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE FLAGSHIP PIONEERING, INC. 2020-06-25 US disclosed
US-20200197428-A1 ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE FLAGSHIP PIONEERING, INC. 2020-06-25 US disclosed
US-20200188418-A1 ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS SENDA BIOSCIENCES, INC. 2020-06-18 US disclosed
US-20200188418-A1 ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS SENDA BIOSCIENCES, INC. 2020-06-18 US disclosed
EP-3645297-A1 IMPROVED METHOD FOR THE PARTIAL COLOURING OF PLASTIC PARTS Covestro Deutschland AG (DE) 2020-05-06 EP disclosed
US-20200122448-A1 FILMS HAVING A SCRATCH-RESISTANT COATING AS A COVER LAYER AND LAYERED COMPOSITES COMPRISING SUCH FILMS COVESTRO DEUTSCHLAND AG (DE) 2020-04-23 US disclosed
EP-3634430-A1 MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME Flagship Pioneering Innovations V, Inc. (US) 2020-04-15 EP disclosed
EP-3630875-A1 FILMS HAVING A SCRATCH-RESISTANT COATING AS A COVER LAYER AND LAYERED COMPOSITES COMPRISING SUCH FILMS Covestro Deutschland AG (DE) 2020-04-08 EP disclosed
US-20200101030-A1 MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME KINTAI THERAPEUTICS, INC. 2020-04-02 US disclosed
WO-2020053169-A1 METHOD FOR MANUFACTURING A LAMINATE WHICH COMPRISES ELECTRONIC COMPONENTS AND/OR FUNTIONAL UNITS COVESTRO DEUTSCHLAND AG (DE) 2020-03-19 WO disclosed
CN-110869024-A Multi-biological agents and methods of use thereof 旗舰创业创新五公司 2020-03-06 CN disclosed
WO-2020039018-A1 IMPROVED METHOD FOR THE PARTIAL COLORING OF PLASTIC PARTS COVESTRO DEUTSCHLAND AG (DE) 2020-02-27 WO disclosed
EP-3611157-A1 SALICYLIC ACID-BASED FUMARATE DERIVATIVE AND USE IN TREATMENT OF PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES Chongqing Neuropark Bioscience Co., Ltd. (CN) 2020-02-19 EP disclosed
US-20200048182-A1 A SALICYL FUMARATE DERIVATIVE AND ITS APPLICATION IN THE TREATMENT OF PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES CHONGQING NEUROPARK BIOSCIENCE CO., LTD. (CN) 2020-02-13 US disclosed
US-10555892-B1 Functionalized siloxane or polysiloxane coated particles with enhanced light filtering properties NANOPHASE TECHNOLOGIES CORPORATION (US) 2020-02-11 US disclosed
CN-110785288-A Improved method for partially coloring plastic parts 科思创德国股份有限公司 2020-02-11 CN disclosed
US-20200039921-A1 ANTIFIBRINOLYTIC COMPOUNDS CHIBBER BAKSHY A (US) 2020-02-06 US disclosed
US-10550346-B2 Quaternized nitrogen compounds and use thereof as additives in fuels and lubricants BASF SE (DE) 2020-02-04 US disclosed
CN-110637050-A Film having a scratch-resistant coating as a cover layer and layered composite comprising such a film 科思创德国股份有限公司 2019-12-31 CN disclosed
EP-3559095-A1 PLASTIC FILMS FOR ID DOCUMENTS HAVING IMPROVED PROPERTIES FOR LASER ENGRAVING AND IMPROVED CHEMICAL RESISTANCE Covestro Deutschland AG (DE) 2019-10-30 EP disclosed
US-10370491-B2 Preparation of highly heat-resistant (co)polycarbonates by the transesterification method COVESTRO DEUTSCHLAND AG (DE) 2019-08-06 US disclosed
WO-2019111048-A1 FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS BASF AS (NO) 2019-06-13 WO disclosed
CN-104045552-B Medicinal compound as neuroprotective agent 江苏先声药业有限公司 2019-06-11 CN disclosed
CN-107200981-B A kind of antiultraviolet plastic matrix and preparation method 浙江乍浦塑料制品有限公司 2019-06-11 CN disclosed
US-10202331-B2 Antifibrinolytic compounds THROMBOLYTICS LLC (US) 2019-02-12 US disclosed
EP-3436284-A1 METHOD FOR THE PARTIAL COLORING OF PLASTIC PARTS Covestro Deutschland AG (DE) 2019-02-06 EP disclosed
CN-208471914-U A kind of new-energy automobile glass 卢洪言 2019-02-05 CN disclosed
US-20190031969-A1 QUATERNIZED NITROGEN COMPOUNDS AND USE THEREOF AS ADDITIVES IN FUELS AND LUBRICANTS BASF SE (DE) 2019-01-31 US disclosed
US-10173355-B2 Method for producing a molded part made of plastic and provided with a UV-cured paint, and said molded part COVESTRO DEUTSCHLAND AG (DE) 2019-01-08 US disclosed
WO-2018226732-A1 MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME FLAGSHIP PIONEERING INNOVATIONS V, INC. (US) 2018-12-13 WO disclosed
US-10131178-B2 Layered structure and films for ID documents having improved properties for laser engraving COVESTRO DEUTSCHLAND AG (DE) 2018-11-20 US disclosed
US-10119085-B2 Quaternized nitrogen compounds and use thereof as additives in fuels and lubricants BASF SE (DE) 2018-11-06 US disclosed
US-20180210362-A1 METHOD OF PRODUCING CURABLE LIQUID DEVELOPER AND CURABLE LIQUID DEVELOPER CANON KK (JP) 2018-07-26 US disclosed
CN-108295262-A The pharmaceutical composition containing anti-inflammatory agent and antioxidant conjugate for treating dysbolism 根梅迪卡治疗公司 2018-07-20 CN disclosed
US-20180201856-A1 QUATERNIZED NITROGEN COMPOUNDS AND USE THEREOF AS ADDITIVES IN FUELS AND LUBRICANTS BASF SE (DE) 2018-07-19 US disclosed
EP-3098657-B1 ULTRAVIOLET-CURABLE LIQUID DEVELOPER AND METHOD OF PRODUCING SAME CANON KK (JP) 2018-07-18 EP disclosed
WO-2018102006-A1 COMPOUNDS FOR THE INHIBITION OF INDOLEAMINE-2,3-DIOXYGENASE ACTIVITY AND USE THEREOF ENSEMBLE THERAPEUTICS CORPORATION (US) 2018-06-07 WO disclosed
WO-2018102006-A1 COMPOUNDS FOR THE INHIBITION OF INDOLEAMINE-2,3-DIOXYGENASE ACTIVITY AND USE THEREOF ENSEMBLE THERAPEUTICS CORPORATION (US) 2018-06-07 WO disclosed
US-9951285-B2 Quaternized nitrogen compounds and use thereof as additives in fuels and lubricants BASF SE (DE) 2018-04-24 US disclosed
WO-2018053302-A1 MACROCYCLIC COMPOUNDS FOR THE INHIBITION OF INDOLEAMINE-2,3-DIOXYGENASE ACTIVITY AND USE THEREOF ENSEMBLE THERAPEUTICS CORPORATION (US) 2018-03-22 WO disclosed
WO-2018053302-A1 MACROCYCLIC COMPOUNDS FOR THE INHIBITION OF INDOLEAMINE-2,3-DIOXYGENASE ACTIVITY AND USE THEREOF ENSEMBLE THERAPEUTICS CORPORATION (US) 2018-03-22 WO disclosed
US-9897936-B2 Method of producing curable liquid developer and curable liquid developer CANON KABUSHIKI KAISHA (JP) 2018-02-20 US disclosed
CN-103945839-B Pharmaceutical combination comprising an anti-inflammatory agent and an antioxidant conjugate for the treatment of metabolic disorders 根梅迪卡治疗公司 2018-02-09 CN disclosed
US-9880482-B2 Ultraviolet-curable liquid developer and method of producing same CANON KABUSHIKI KAISHA (JP) 2018-01-30 US disclosed
US-20170369642-A1 Preparation of Highly Heat-Resistant (Co)Polycarbonates by the Transesterification Method COVESTRO DEUTSCHLAND AG (DE) 2017-12-28 US disclosed
WO-2017205772-A1 FUEL COMPOSITION WITH REDUCED CAVITATION AND METHODS OF USE THE LUBRIZOL CORPORATION (US) 2017-11-30 WO disclosed
EP-3247734-A1 PREPARATION OF HIGHLY HEAT-RESISTANT (EO)POIYCARBONATES BY THE TRANSESTERIFICATION METHOD Covestro Deutschland AG (DE) 2017-11-29 EP disclosed
CN-107382144-A One kind is floatd the heat-resisting UV resistant quartz stone composite material of window table 宿松圣峰装饰材料有限公司 2017-11-24 CN disclosed
CN-107382144-A One kind is floatd the heat-resisting UV resistant quartz stone composite material of window table 宿松圣峰装饰材料有限公司 2017-11-24 CN disclosed
US-20170334834-A1 ANTIFIBRINOLYTIC COMPOUNDS THROMBOLYTICS, LLC (US) 2017-11-23 US disclosed
CN-107325601-A A kind of water-repellent modified coating of UV resistant 天长市巨龙车船涂料有限公司 2017-11-07 CN disclosed
CN-107200981-A A kind of antiultraviolet plastic matrix and preparation method 成都新柯力化工科技有限公司 2017-09-26 CN disclosed
US-9766568-B2 Ultraviolet-curable liquid developer CANON KABUSHIKI KAISHA (JP) 2017-09-19 US disclosed
EP-3215145-A2 ANTIFIBRINOLYTIC COMPOUNDS Thromboltyics, LLC (US) 2017-09-13 EP disclosed
US-20170176881-A1 LIQUID DEVELOPER SAKATA INX CORPORATION (JP) 2017-06-22 US disclosed
US-20170168410-A1 LIQUID DEVELOPER SAKATA INX CORPORATION (JP) 2017-06-15 US disclosed
US-9676939-B2 Heat resistant clear polycarbonate-polysiloxane compounds SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2017-06-13 US disclosed
US-9676939-B2 Heat resistant clear polycarbonate-polysiloxane compounds SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2017-06-13 US disclosed
EP-2820071-B1 PROCESS FOR THE PRODUCTION OF LOW STRESS AND OPTICAL QUALITY FILM FOR USE IN OPTO-ELECTRONIC DEVICES COVESTRO DEUTSCHLAND AG (DE) 2017-03-22 EP disclosed
CN-106517810-A High-safety ultraviolet-proof automotive glass and preparation method thereof 重庆动沃机车产业有限公司 2017-03-22 CN disclosed
CN-106478500-A Carboxylic acid-substituted(Miscellaneous)Aromatic ring analog derivative and its production and use 广东东阳光药业有限公司 2017-03-08 CN disclosed
US-9562133-B2 Cross-linked polycarbonate resin with improved chemical and flame resistance SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2017-02-07 US disclosed
CN-106336125-A Automotive glass 重庆东科模具制造有限公司 2017-01-18 CN disclosed
US-9546244-B2 Cross-linked polycarbonate resin with improved chemical and flame resistance SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2017-01-17 US disclosed
US-20170010555-A1 LIQUID DEVELOPER SAKATA INX CORPORATION (JP) 2017-01-12 US disclosed
EP-3104226-A1 LIQUID DEVELOPER Sakata INX Corp. (JP) 2016-12-14 EP disclosed
EP-3104227-A1 LIQUID DEVELOPER Sakata INX Corp. (JP) 2016-12-14 EP disclosed
EP-3104225-A1 LIQUID DEVELOPER Sakata INX Corp. (JP) 2016-12-14 EP disclosed
US-20160349656-A1 ULTRAVIOLET-CURABLE LIQUID DEVELOPER AND METHOD OF PRODUCING SAME CANON KABUSHIKI KAISHA (JP) 2016-12-01 US disclosed
US-20160349652-A1 METHOD OF PRODUCING CURABLE LIQUID DEVELOPER AND CURABLE LIQUID DEVELOPER CANON KABUSHIKI KAISHA (JP) 2016-12-01 US disclosed
EP-3098657-A1 ULTRAVIOLET-CURABLE LIQUID DEVELOPER AND METHOD OF PRODUCING SAME Canon Kabushiki Kaisha (JP) 2016-11-30 EP disclosed
US-9499693-B2 Clean polycarbonate material for use in hard disk drive and semiconductor applications SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2016-11-22 US disclosed
CN-102639494-B Sulphones and preparation and application thereof 扎夫根公司 2016-11-09 CN disclosed
US-9481761-B2 Cross-linked polycarbonate resin with improved chemical and flame resistance SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2016-11-01 US disclosed
EP-3076241-A1 ULTRAVIOLET-RAY-CURABLE LIQUID DEVELOPER Canon Kabushiki Kaisha (JP) 2016-10-05 EP disclosed
US-20160251588-A1 USE OF QUATERNIZED ALKYL AMINES AS ADDITIVE IN FUELS AND LUBRICANTS BASF SE (DE) 2016-09-01 US disclosed
US-9429863-B2 Liquid developing agent SAKATA INX CORPORATION (JP) 2016-08-30 US disclosed
WO-2016116480-A1 PREPARATION OF HIGHLY HEAT-RESISTANT (EO)POIYCARBONATES BY THE TRANSESTERIFICATION METHOD COVESTRO DEUTSCHLAND AG (DE) 2016-07-28 WO disclosed
CN-205398799-U Synthetic fiber with antibiotic anti ultraviolet economic benefits and social benefits function 摩登大道时尚集团股份有限公司 2016-07-27 CN disclosed
US-9394483-B2 Flame retardant polycarbonate compositions, methods of manufacture thereof and articles comprising the same SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2016-07-19 US disclosed
CN-103748094-B Tricyclic sulfonamide compounds and methods of making and using the same 扎夫根股份有限公司 2016-06-29 CN disclosed
WO-2016073493-A2 ANTIFIBRINOLYTIC COMPOUNDS THROMBOLTYICS, LLC (US) 2016-05-12 WO disclosed
CN-103429428-B Laminate for protecting metals from corrosive gases NORTHERN TECHNOLOGIES INTERNATIONAL CORP. (US) 2016-04-27 CN disclosed
US-9309407-B2 Polycarbonate-siloxane copolymer flame retarded with a silicone based core shell modifier SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2016-04-12 US disclosed
CN-105399338-A High-strength ultraviolet-proof automotive glass and preparation method thereof CHEN GUIXING 2016-03-16 CN disclosed
US-20150370190-A1 LIQUID DEVELOPING AGENT SAKATA INX CORPORATION (JP) 2015-12-24 US disclosed
EP-2955579-A1 LIQUID DEVELOPING AGENT Sakata INX Corp. (JP) 2015-12-16 EP disclosed
US-20150315336-A1 CROSS-LINKED POLYCARBONATE RESIN WITH IMPROVED CHEMICAL AND FLAME RESISTANCE SABIC GLOBAL TECHNOLOGIES B.V. 2015-11-05 US disclosed
US-20150307706-A1 HEAT RESISTANT CLEAR POLYCARBONATE-POLYSILOXANE COMPOUNDS SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2015-10-29 US disclosed
US-20150252277-A1 QUATERNIZED POLYETHER AMINES AND THEIR USE AS ADDITIVE FOR FUELS AND LUBRICANTS BASF SE (DE) 2015-09-10 US disclosed
US-20150239159-A1 METHOD FOR PRODUCING A MOLDED PART MADE OF PLASTIC AND PROVIDED WITH A UV-CURED PAINT, AND SAID MOLDED PART BAYER MATERIAL SCIENCE AG 2015-08-27 US disclosed
US-9115283-B2 Heat resistant clear polycarbonate-polysiloxane compounds SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2015-08-25 US disclosed
US-9108357-B2 Multilayer decorative film BAYER INTELLECTUAL PROPERTY GMBH (DE) 2015-08-18 US disclosed
US-9102597-B2 Indane bisphenols, polymers derived therefrom, and methods of use thereof SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2015-08-11 US disclosed
US-9102598-B2 Indane bisphenols, polymers derived therefrom, and methods of use thereof SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2015-08-11 US disclosed
US-20150197609-A1 CROSS-LINKED POLYCARBONATE RESIN WITH IMPROVED CHEMICAL AND FLAME RESISTANCE SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2015-07-16 US disclosed
US-9079443-B2 ID cards with blocked laser engraving writability BAYER MATERIALSCIENCE AG (DE) 2015-07-14 US disclosed
US-20150192875-A1 ULTRAVIOLET-CURABLE LIQUID DEVELOPER CANON KABUSHIKI KAISHA (JP) 2015-07-09 US disclosed
US-20150159103-A1 QUATERNIZED NITROGEN COMPOUNDS AND USE THEREOF AS ADDITIVES IN FUELS AND LUBRICANTS BASF SE (DE) 2015-06-11 US disclosed
CN-102099015-B Articles of manufacture releasing an active ingredient BIOMOD CONCEPTS INC 2015-05-06 CN disclosed
US-9023923-B2 Flame retardant polycarbonate compositions, methods of manufacture thereof and articles comprising the same SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2015-05-05 US disclosed
US-9023973-B2 Cross-linked polycarbonate resin with improved chemical and flame resistance SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2015-05-05 US disclosed
US-9018286-B2 Flame retardant polycarbonate compositions, methods of manufacture thereof and articles comprising the same SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2015-04-28 US disclosed
US-8993671-B2 Poly(aliphatic ester)-polycarbonate copolymer/polylactic acid blend Sabic Global Technolgies B.V. (NL) 2015-03-31 US disclosed
US-20150025006-A1 Pharmaceutical Combinations Including Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders GENMEDICA THERAPEUTICS SL (ES) 2015-01-22 US disclosed
EP-2820071-A1 PROCESS FOR THE PRODUCTION OF LOW STRESS AND OPTICAL QUALITY FILM FOR USE IN OPTO-ELECTRONIC DEVICES Bayer Intellectual Property GmbH (DE) 2015-01-07 EP disclosed
US-8927661-B2 Flame retardant polycarbonate compositions, methods of manufacture thereof and articles comprising the same SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2015-01-06 US disclosed
US-8916270-B2 Glass filled copolymer products for thin wall and high surface gloss articles SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2014-12-23 US disclosed
US-20140371360-A1 FLAME RETARDANT POLYCARBONATE COMPOSITIONS, METHODS OF MANUFACTURE THEREOF AND ARTICLES COMPRISING THE SAME SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2014-12-18 US disclosed
US-8895649-B2 Flame retardant polycarbonate compositions, methods of manufacture thereof and articles comprising the same SABIC GLOBAL TECHNOLOGIES B.V. (NL) 2014-11-25 US disclosed
US-20140329920-A1 POLYCARBONATE-SILOXANE COPOLYMER FLAME RETARDED WITH A SILICONE BASED CORE SHELL MODIFIER SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2014-11-06 US disclosed
US-20140296580-A1 INDANE BISPHENOLS, POLYMERS DERIVED THEREFROM, AND METHODS OF USE THEREOF SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2014-10-02 US disclosed
US-20140295363-A1 PLASTIC FLAME HOUSING AND METHOD OF MAKING THE SAME SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-10-02 US disclosed
CN-102427809-B Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders GENMEDICA THERAPEUTICS S.L. (ES) 2014-10-01 CN disclosed
US-8841367-B2 Flame retardant polycarbonate compositions, methods of manufacture thereof and articles comprising the same SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-09-23 US disclosed
CN-104045552-A Medicinal compound as neuroprotective agent SHANGHAI SIMCERE PHARMACEUTICAL RES CO LTD 2014-09-17 CN disclosed
US-20140234629-A1 HIGH HEAT POLYCARBONATE AND SILOXANE COPOLYCARBONATE BLENDS THAT PROVIDE DUCTILE HIGH HEAT OPTIONS FOR FLAME RETARDANT APPLICATIONS SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-08-21 US disclosed
EP-2755645-A1 PHARMACEUTICAL COMBINATIONS INCLUDING ANTI-INFLAMMATORY AND ANTIOXIDANT CONJUGATES USEFUL FOR TREATING METABOLIC DISORDERS Genmedica Therapeutics SL (ES) 2014-07-23 EP disclosed
CN-103945839-A Pharmaceutical combination comprising an anti-inflammatory agent and an antioxidant conjugate for the treatment of metabolic disorders GENMEDICA THERAPEUTICS SL 2014-07-23 CN disclosed
US-20140179817-A1 CROSS-LINKED POLYCARBONATE RESIN WITH IMPROVED CHEMICAL AND FLAME RESISTANCE SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-06-26 US disclosed
US-20140179844-A1 CROSS-LINKED POLYCARBONATE RESIN WITH IMPROVED CHEMICAL AND FLAME RESISTANCE SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-06-26 US disclosed
US-20140124709-A1 CLEAN POLYCARBONATE MATERIAL FOR USE IN HARD DISK DRIVE AND SEMICONDUCTOR APPLICATIONS SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-05-08 US disclosed
US-20140061533-A1 INDANE BISPHENOLS, POLYMERS DERIVED THEREFROM, AND METHODS OF USE THEREOF SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2014-03-06 US disclosed
EP-2694698-A1 A PROCESS FOR MULTI-LAYER CONTINUOUS ROLL-TO-ROLL COATING Bayer Intellectual Property GmbH (DE) 2014-02-12 EP disclosed
US-8633265-B2 UV stabilization of isosorbide polycarbonates SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2014-01-21 US disclosed
US-20130296210-A1 USE OF QUATERNIZED ALKYL AMINES AS ADDITIVE IN FUELS AND LUBRICANTS BASF SE (DE) 2013-11-07 US disclosed
US-8575217-B2 Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders GENMEDICA THERAPEUTICS SL (ES) 2013-11-05 US disclosed
US-20130281520-A1 Anti-Inflammatory And Antioxidant Conjugates Useful For Treating Metabolic Disorders GENMEDICA THERAPEUTICS SL (ES) 2013-10-24 US disclosed
US-20130267726-A1 Thiocarbonates as Anti-Inflammatory and Antioxidant Compounds Useful For Treating Metabolic Disorders GENMEDICA THERAPEUTICS SL (ES) 2013-10-10 US disclosed
EP-2640581-A1 MULTILAYER DECORATIVE FILM Bayer Intellectual Property GmbH (DE) 2013-09-25 EP disclosed
US-20130236719-A1 MULTILAYER DECORATIVE FILM COVESTRO DEUTSCHLAND AG (DE) 2013-09-12 US disclosed
WO-2013127851-A1 PROCESS FOR THE PRODUCTION OF LOW STRESS AND OPTICAL QUALITY FILM FOR USE IN OPTO-ELECTRONIC DEVICES BAYER MATERIALSCIENCE AG (DE) 2013-09-06 WO disclosed
EP-2634208-A1 Process for the production of low stress and optical quality film for use in opto-electronic devices Bayer MaterialScience AG (DE) 2013-09-04 EP disclosed
US-20130225463-A1 QUATERNIZED POLYETHER AMINES AND THEIR USE AS ADDITIVE FOR FUELS AND LUBRICANTS BASF SE (DE) 2013-08-29 US disclosed
US-20130196131-A1 GLASS FILLED COPOLYMER PRODUCTS FOR THIN WALL AND HIGH SURFACE GLOSS ARTICLES SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2013-08-01 US disclosed
EP-1956438-B1 LIQUID DEVELOPER SAKATA INX CORP (JP) 2013-07-24 EP disclosed
US-8466197-B2 Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders GENMEDICA THERAPEUTICS SL (ES) 2013-06-18 US disclosed
US-20130137804-A1 POLY(ALIPHATIC ESTER)- POLYCARBONATE COPOLYMER/POLYLACTIC ACID BLEND SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2013-05-30 US disclosed
US-20130133243-A1 QUATERNIZED NITROGEN COMPOUNDS AND USE THEREOF AS ADDITIVES IN FUELS AND LUBRICANTS BASF SE (DE) 2013-05-30 US disclosed
EP-2584896-A2 HERBICIDAL COMPOSITIONS BASF SE (DE) 2013-05-01 EP disclosed
US-20130102463-A1 Herbicidal Compositions BASF SE (DE) 2013-04-25 US disclosed
WO-2013037985-A1 PHARMACEUTICAL COMBINATIONS INCLUDING ANTI-INFLAMMATORY AND ANTIOXIDANT CONJUGATES USEFUL FOR TREATING METABOLIC DISORDERS GENMEDICA THERAPUTICS SL (ES) 2013-03-21 WO disclosed
CN-102958361-A Herbicidal compositions BASF SE 2013-03-06 CN disclosed
US-8389196-B2 Method of preparing toner SAMSUNG FINE CHEMICALS CO., LTD. (KR) 2013-03-05 US disclosed
US-20130046013-A1 SALICYLATE FATTY ACID DERIVATIVES HOVLAND RAGNAR (NO) 2013-02-21 US disclosed
CN-102127023-B 7-membered ring compound, process for producing the same, and use thereof DAIICHI SANKYO CO LTD 2013-02-06 CN disclosed
CN-102822141-A Salicylate fatty acid derivatives PRONOVA BIOPHARMA NORGE AS 2012-12-12 CN disclosed
US-20120264671-A1 METHODS AND COMPOSITIONS FOR REMOVING RESIDUES AND SUBSTANCES FROM SUBSTRATES USING ENVIRONMENTALLY FRIENDLY SOLVENTS CARBONELL RUBEN G (US) 2012-10-18 US disclosed
WO-2012136529-A1 A PROCESS FOR MULTI-LAYER CONTINUOUS ROLL-TO-ROLL COATING BAYER MATERIALSCIENCE AG (DE) 2012-10-11 WO disclosed
EP-2508646-A1 A process for multi-layer continuous roll-to-roll coating Bayer Material Science AG (DE) 2012-10-10 EP disclosed
US-20120252985-A1 HEAT RESISTANT CLEAR POLYCARBONATE-POLYSILOXANE COMPOUNDS SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2012-10-04 US disclosed
CN-101495463-B Seven-membered ring compound, production method thereof and pharmaceutical use thereof DAIICHI SANKYO CO LTD 2012-08-15 CN disclosed
US-20120184651-A1 UV Stabilization of Isosorbide Polycarbonates SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2012-07-19 US disclosed
EP-2473265-A1 MASTERBATCH COMPOSITION HAVING A HIGH POLYMER PROCESSING AID Carolina Color Corporation (US) 2012-07-11 EP disclosed
CN-101542396-B A toner manufacturing method, a toner manufacturing apparatus, and a toner RICOH CO LTD 2012-06-27 CN disclosed
WO-2012080371-A1 NEW THIOCARBONATES AS ANTI-INFLAMMATORY AND ANTIOXIDANT COMPOUNDS USEFUL FOR TREATING METABOLIC DISORDERS GENMEDICA THERAPEUTICS SL (ES) 2012-06-21 WO disclosed
US-8201445-B2 Methods and compositions for removing residues and substances from substrates using environmentally friendly solvents NORTH CAROLINA STATE UNIVERSITY (US) 2012-06-19 US disclosed
US-20120149769-A1 Thiocarbonates as Anti-Inflammatory and Antioxidant Compounds Useful For Treating Metabolic Disorders GENMEDICA THERAPEUTICS SL (ES) 2012-06-14 US disclosed
WO-2012065966-A1 MULTILAYER DECORATIVE FILM BAYER MATERIALSCIENCE AG (DE) 2012-05-24 WO disclosed
US-8168110-B2 Method for producing a deep-drawn film part from a thermoplastic material BAYER MATERIALSCIENCE AG (DE) 2012-05-01 US disclosed
CN-102427809-A Anti-inflammatory and antioxidant conjugates useful for treating metabolic disorders GENMEDICA THERAPEUTICS SL 2012-04-25 CN disclosed
US-8114858-B2 Derivatives of 4- or 5-aminosalicylic acid ANTIBE THERAPEUTICS INC. (CA) 2012-02-14 US disclosed
US-8114857-B2 Derivatives of 4- or 5-aminosalicylic acid ANTIBE THERAPEUTICS INC. (CA) 2012-02-14 US disclosed
EP-2408443-A1 ANTI-INFLAMMATORY AND ANTIOXIDANT CONJUGATES USEFUL FOR TREATING METABOLIC DISORDERS Genmedica Therapeutics SL (ES) 2012-01-25 EP disclosed
US-20120001413-A1 LAYER STRUCTURE AND FILMS FOR ID DOCUMENTS HAVING IMPROVED PROPERTIES FOR LASER ENGRAVING BAYER MATERIALSCIENCE AG (DE) 2012-01-05 US disclosed
WO-2011161105-A2 HERBICIDAL COMPOSITIONS BASF SE (DE) 2011-12-29 WO disclosed
US-20110288057-A1 SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS NOVARTIS AG (CH) 2011-11-24 US disclosed
CN-102186803-A Salicylic acid derivatives being farnesyl pyrophosphate synthase activity inhibitors NOVARTIS AG 2011-09-14 CN disclosed
US-8006551-B2 Methods and compositions for removing residues and substances from substrates using environmentally friendly solvents NORTH CAROLINA STATE UNIVERSITY (US) 2011-08-30 US disclosed
US-20110206908-A1 USE OF A PLASTIC FILM IN COLOUR LASER PRINTING BAYER MATERIAL SCIENCE AG (DE) 2011-08-25 US disclosed
US-20110200801-A1 ID CARDS WITH BLOCKED LASER ENGRAVING WRITABILITY BAYER MATERIAL SCIENCE AG (DE) 2011-08-18 US disclosed
US-20110177454-A1 RESIST MATERIAL AND PATTERN FORMATION METHOD USING THE RESIST MATERIAL PANASONIC CORPORATION (JP) 2011-07-21 US disclosed
CN-102127023-A 7-membered ring compound, process for producing the same, and use thereof DAIICHI ASUBIO PHARMA CO LTD 2011-07-20 CN disclosed
US-20110144371-A1 PROCESS FOR PURIFYING DIALKYL CARBONATES BAYER MATERIALSCIENCE AG (DE) 2011-06-16 US disclosed
US-20110130368-A1 DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID ANTIBE THERAPEUTICS INC. (CA) 2011-06-02 US disclosed
US-20110098257-A1 DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID ANTIBE THERAPEUTICS INC. (CA) 2011-04-28 US disclosed
US-7910568-B2 Inflammatory bowel disease, irritable bowel syndrome, Crohn's disease, ulcerative colitis, gastrointestinal disorders; prevention/treatment of colon cancer; releases hydrogen sulfide ANTIBE THERAPEUTICS INC. (CA) 2011-03-22 US disclosed
WO-2011028206-A1 MASTERBATCH COMPOSITION HAVING A HIGH POLYMER PROCESSING AID CAROLINA COLOR CORPOARTION (US) 2011-03-10 WO disclosed
US-7879827-B2 such as 5-amino-2-(2-Acetylamino-3-mercapto-propionyloxy)-benzoic acid, useful for the treatment of gastrointestinal disorders such as inflammatory bowel disease and irritable bowel syndrome, and for the prevention/treatment of colon cancer ANTIBE THERAPEUTICS INC. (CA) 2011-02-01 US disclosed
CN-101160290-B 7-membered ring compound, process for producing the same, and pharmaceutical use thereof DAIICHI SANKYO CO LTD 2011-01-19 CN disclosed
US-7851117-B2 Liquid developer SAKATA INX CORP. (JP) 2010-12-14 US disclosed
US-20100288028-A1 Methods and Compositions for Removing Residues and Substances from Substrates Using Environmentally Friendly Solvents CARBONELL RUBEN G 2010-11-18 US disclosed
US-7814626-B2 Process for the preparation of polycarbonate by the melt transesterification process BAYER MATERIALSCIENCE AG (DE) 2010-10-19 US disclosed
US-7807772-B2 Aliphatic diol-based polycarbonates, method of making, and articles formed therefrom SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-10-05 US disclosed
US-20100237544-A1 METHOD FOR PRODUCING A DEEP-DRAWN FILM PART FROM A THERMOPLASTIC MATERIAL BAYER MATERIALSCIENCE AG (DE) 2010-09-23 US disclosed
WO-2010106082-A1 ANTI-INFLAMMATORY AND ANTIOXIDANT CONJUGATES USEFUL FOR TREATING METABOLIC DISORDERS GENMEDICA THERAPEUTICS SL (ES) 2010-09-23 WO disclosed
US-20100234452-A1 Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders GENMEDICA THERAPEUTICS SL (ES) 2010-09-16 US disclosed
US-7786246-B2 Isosorbide-based polycarbonates, method of making, and articles formed therefrom SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-08-31 US disclosed
US-7786246-B2 Isosorbide-based polycarbonates, method of making, and articles formed therefrom SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-08-31 US disclosed
US-20100216069-A1 METHOD OF PREPARING TONER SAMSUNG FINE CHEMICALS CO. LTD (KR) 2010-08-26 US disclosed
US-7718755-B2 Aliphatic diol-based polycarbonates, method of making, and articles formed therefrom SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-05-18 US disclosed
US-20100120993-A1 ALIPHATIC DIOL-BASED POLYCARBONATES, METHOD OF MAKING, AND ARTICLES FORMED THEREFROM SABIC INNOVATIVE PLASTICS, IP B.V. (NL) 2010-05-13 US disclosed
US-20100099832-A1 ISOSORBIDE-BASED POLYCARBONATES, METHOD OF MAKING, AND ARTICLES FORMED THEREFROM SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-04-22 US disclosed
US-20100099832-A1 ISOSORBIDE-BASED POLYCARBONATES, METHOD OF MAKING, AND ARTICLES FORMED THEREFROM SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-04-22 US disclosed
US-7666972-B2 Isosorbide-based polycarbonates, method of making, and articles formed therefrom SABIC Innovative Plastics IP B., V. (NL) 2010-02-23 US disclosed
US-20090246678-A1 LIQUID DEVELOPER SAKATA INX CORP. (JP) 2009-10-01 US disclosed
CN-101542396-A A toner manufacturing method, a toner manufacturing apparatus, and a toner RICOH KK (JP) 2009-09-23 CN disclosed
US-20090233886-A1 DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID ANTIBE THERAPEUTICS INC. (CA) 2009-09-17 US disclosed
CN-101495463-A Seven-membered ring compound, production method thereof and pharmaceutical use thereof ASUBIO PHARMA CO LTD (JP) 2009-07-29 CN disclosed
US-20090120170-A1 Methods and Compositions for Removing Residues and Substances from Substrates Using Environmentally Friendly Solvents CARBONELL RUBEN G 2009-05-14 US disclosed
US-20090117314-A1 PROCESS FOR THE PREPARATION OF POLYCARBONATE BY THE MELT TRANSESTERIFICATION METHOD BAYER MATERIALSCIENCE AG (DE) 2009-05-07 US disclosed
US-20090105393-A1 ISOSORBIDE-BASED POLYCARBONATES, METHOD OF MAKING, AND ARTICLES FORMED THEREFROM SHPP GLOBAL TECHNOLOGIES B.V. (NL) 2009-04-23 US disclosed
US-20090105444-A1 ALIPHATIC DIOL-BASED POLYCARBONATES, METHOD OF MAKING, AND ARTICLES FORMED THEREFROM SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2009-04-23 US disclosed
WO-2009038404-A2 METHOD OF PREPARING TONER SAMSUNG FINE CHEMICALS CO., LTD. (KR) 2009-03-26 WO disclosed
US-20090062322-A1 Novel Tricyclic Spiropiperidines or Spiropyrrolidines ASTRAZENECA AB (SE) 2009-03-05 US disclosed
US-7498355-B2 Derivatives of 4- or 5-aminosalicylic acid ANTIBE THERAPEUTICS INC. (CA) 2009-03-03 US disclosed
US-20080319156-A1 Process For The Preparation Of Polycarbonate By The Melt Transesterification Process BAYER MATERIALSCIENCE AG (DE) 2008-12-25 US disclosed
US-7465395-B2 Methods and compositions for removing residues and substances from substrates using environmentally friendly solvents NORTH CAROLINA STATE UNIVERSITY (US) 2008-12-16 US disclosed
EP-0979438-B1 PROCESS FOR MAKING PARTICULATE COMPOSITIONS FUJIFILM IMAGING COLORANTS LTD (GB) 2008-12-03 EP disclosed
US-7449475-B2 Tricyclic spiropiperidines or spiropyrrolidines ASTRAZENECA AB (SE) 2008-11-11 US disclosed
US-20080207564-A1 Derivaitves of 4-Or 5-Aminosalicylic Acid ANTIBE THERAPEUTICS INC. (CA) 2008-08-28 US disclosed
WO-2008098929-A1 METHOD FOR PREPARING POLYESTER-POLYOLEFIN HYBRID PARTICLES DSM IP ASSETS B.V. (NL) 2008-08-21 WO disclosed
EP-1956438-A1 LIQUID DEVELOPER Sakata Inx Corporation (JP) 2008-08-13 EP disclosed
CN-100406439-C Pyrrolidine derivatives as metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2008-07-30 CN disclosed
US-20080146695-A1 preparing a polyetherurethane prepolymer by reactinglargely linear polyether polyols having predominantly secondary OH groups, with one or more diisocyanates in presence of zinc catalyst (free of tin), reacting propolymer with an aminoalkylsilanes to form silane terminated polyether; dental moldings BAYER MATERIALSCIENCE AG (DE) 2008-06-19 US disclosed
WO-2008043654-A2 BLOND CLEAR TREATMENT HENKEL AG & CO. KGAA (DE) 2008-04-17 WO disclosed
CN-101160290-A 7-membered ring compound, process for producing the same, and pharmaceutical use thereof ASUBIO PHARMA CO LTD (JP) 2008-04-09 CN disclosed
EP-1521757-B1 TRICYCLIC SPIROPIPERIDINES OR SPIROPYRROLIDINES ASTRAZENECA AB (SE) 2008-01-30 EP disclosed
US-7300733-B2 Black toner with defined loss tangent CANON KABUSHIKI KAISHA (JP) 2007-11-27 US disclosed
US-7279544-B2 Transesterification process for the production of polycarbonates having a low content of volatile compounds BAYER MATERIALSCIENCE AG (DE) 2007-10-09 US disclosed
EP-1084458-B1 PROCESS FOR MAKING PARTICULATE COMPOSITIONS FUJIFILM IMAGING COLORANTS LTD (GB) 2007-09-05 EP disclosed
US-20070197479-A1 Derivatives of 4- or 5-aminosalicylic acid ANTIBE THERAPEUTICS INC. (CA) 2007-08-23 US disclosed
US-20070197479-A1 Derivatives of 4- or 5-aminosalicylic acid ANTIBE THERAPEUTICS INC. (CA) 2007-08-23 US disclosed
US-7250483-B2 Inhibition of catalytically active impurities in polycarbonate by the melt transesterification process BAYER MATERIALSCIENCE AG (DE) 2007-07-31 US disclosed
US-20070095753-A1 Methods and compositions for removing residues and substances from substrates using environmentally friendly solvents CARBONELL RUBEN G 2007-05-03 US disclosed
US-7189756-B2 Pyrrolidine derivatives HOFFMAN-LA ROCHE INC. (US) 2007-03-13 US disclosed
CN-1882324-A Substituted aryloximes WYETH CORP (US) 2006-12-20 CN disclosed
US-7091302-B2 Process for the preparation of polycarbonate BAYER MATERIALSCIENCE AG (DE) 2006-08-15 US disclosed
US-7053401-B2 Synthesis and application of photosensitive pentacene precursor in organic thin film transistors INTERNATIONAL BUSINESS MACHINES CORPORATION (US) 2006-05-30 US disclosed
US-7022449-B2 Black toner with defined loss tangent CANON KABUSHIKI KAISHA (JP) 2006-04-04 US disclosed
EP-0921440-B1 METHODS OF FORMING RAISED AND RECESSED PATTERNS AND USE OF THE PATTERNS IN THE MANUFACTURE OF LIQUID CRYSTAL DISPLAY COLOR FILTERS DAINIPPON PRINTING CO LTD (JP) 2006-02-22 EP disclosed
US-20060014095-A1 Black toner with defined loss tangent CANON KABUSHIKI KAISHA (JP) 2006-01-19 US disclosed
US-20060004178-A1 Inhibition of catalytically active impurities in polycarbonate by the melt transesterification process COVESTRO DEUTSCHLAND AG (DE) 2006-01-05 US disclosed
US-20050288407-A1 Thermally stabilized polycarbonate composition BAYER MATERIALSCIENCE AG 2005-12-29 US disclosed
US-6974658-B2 HIGH MOLECULAR COMPOUND, MONOMER COMPOUNDS AND PHOTOSENSITIVE COMPOSITION FOR PHOTORESIST, PATTERN FORMING METHOD UTILIZING PHOTOSENSITIVE COMPOSITION, AND METHOD OF MANUFACTURING ELECTRONIC COMPONENTS KABUSHIKI KAISHA TOSHIBA (JP) 2005-12-13 US disclosed
US-20050245741-A1 Novel tricyclic spiropiperidines or spiropyrrolidines ASTRAZENECA AB (SE) 2005-11-03 US disclosed
US-20050239995-A1 Process for the preparation of polycarbonate BAYER MATERIALSCIENCE AG 2005-10-27 US disclosed
CN-1214287-C Black matrix for color picture tube and method of producing the same SAMSUNG DISPLAY DEVICES CO LTD (KR) 2005-08-10 CN disclosed
US-20050130941-A1 Methods of treating alzheimer's disease PHARMACIA & UPJOHN COMPANY LLC 2005-06-16 US disclosed
US-20050131197-A1 Transesterification process for the production of polycarbonates having a low content of volatile compounds COVESTRO DEUTSCHLAND AG (DE) 2005-06-16 US disclosed
EP-1521757-A1 NOVEL TRICYCLIC SPIROPIPERIDINES OR SPIROPYRROLIDINES AstraZeneca AB (SE) 2005-04-13 EP disclosed
EP-1490469-A2 METHODS AND COMPOSITIONS FOR REMOVING RESIDUES AND SUBSTANCES FROM SUBSTRATES USING ENVIRONMENTALLY FRIENDLY SOLVENTS North Carolina State University (US) 2004-12-29 EP disclosed
US-20040242672-A1 Useful as inhibitors of metalloproteases, e.g. zinc proteases; effective in treating disease states associated with vasoconstriction such as high blood pressure, coronary disorders, cardiac insufficiency, renal and myocardial ischaemia, renal insufficiency, dialysis, cerebral ischaemia AEBI JOHANNES (CH) 2004-12-02 US disclosed
US-6790860-B2 USEFUL AS INHIBITORS OF METALLOPROTEASES, E.G. ZINC PROTEASES; EFFECTIVE IN TREATING DISEASE STATES ASSOCIATED WITH VASOCONSTRICTION HOFFMANN-LA ROCHE INC. 2004-09-14 US disclosed
US-20040119073-A1 Synthesis and application of photosensitive pentacene precursor in organic thin film transistors INTERNATIONAL BUSINESS MACHINES CORPORATION 2004-06-24 US disclosed
EP-1388762-A2 Black toner CANON KABUSHIKI KAISHA (JP) 2004-02-11 EP disclosed
WO-2004005295-A1 NOVEL TRICYCLIC SPIROPIPERIDINES OR SPIROPYRROLIDINES ASTRAZENECA AB (SE) 2004-01-15 WO disclosed
US-20030199569-A1 Pyrrolidine derivatives AEBI JOHANNES (CH) 2003-10-23 US disclosed
CN-1443164-A Pyrrolidine derivatives as metalloprotease inhibitors HOFFMANN LA ROCHE (CH) 2003-09-17 CN disclosed
WO-2003072215-A2 METHODS AND COMPOSITIONS FOR REMOVING RESIDUES AND SUBSTANCES FROM SUBSTRATES USING ENVIRONMENTALLY FRIENDLY SOLVENTS NORTH CAROLINA STATE UNIVERSITY (US) 2003-09-04 WO disclosed
US-20030134218-A1 Process for making particulate compositions AVECIA LIMITED (GB) 2003-07-17 US disclosed
EP-1322616-A2 QUINOLINE-(C=O)-(DI-, TRI- AND TETRAPEPTIDE) DERIVATIVES AS CASPASE INHIBITORS ENZYME SYSTEMS PRODUCTS INC. (US) 2003-07-02 EP disclosed
EP-1303486-A1 PYRROLIDINE DERIVATIVES AS METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2003-04-23 EP disclosed
US-6531256-B1 Process for making particulate compositions AVECIA LIMITED (GB) 2003-03-11 US disclosed
US-6531254-B1 Process for making particulate compositions AVECIA LIMITED (GB) 2003-03-11 US disclosed
CN-1396151-A Tert-butyl salicylic acid complex and its preparing process DINGLONG CHEMICAL CO LTD HUBEI (CN) 2003-02-12 CN disclosed
CN-1396151-A Tert-butyl salicylic acid complex and its preparing process DINGLONG CHEMICAL CO LTD HUBEI (CN) 2003-02-12 CN disclosed
US-6518379-B1 Used for preparing high-impact polystyrene, acrylonitrile-butadiene-styrene copolymers or methyl methacrylate-butadiene-styrene copolymers BASF AKTIENGESELLSCHAFT (DE) 2003-02-11 US disclosed
WO-2002018341-A9 QUINOLINE- (C=O) - (DI-, TRI- AND TETRAPEPTIDE) DERIVATIVES AS CASPASE INHIBITORS ENZYME SYST PROD INC (US) 2002-11-21 WO disclosed
US-6413679-B1 HERMETIC SEALED CONTAINER KABUSHIKI KAISHA TOSHIBA (JP) 2002-07-02 US disclosed
US-20020052323-A1 Quinoline-(C=O)-(multiple amino acids)-leaving group compounds for pharmaceutical compositions and reagents MP BIOMEDICALS, LLC 2002-05-02 US disclosed
US-20020040146-A1 Pyrrolidine derivatives F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2002-04-04 US disclosed
WO-2002018341-A2 QUINOLINE- (C=O) - (DI-, TRI- AND TETRAPEPTIDE) DERIVATIVES AS CASPASE INHIBITORS ENZYME SYSTEMS PRODUCTS, INC. (US) 2002-03-07 WO disclosed
WO-2002008185-A1 PYRROLIDINE DERIVATIVES AS METALLOPROTEASE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2002-01-31 WO disclosed
WO-2002006392-A1 STABILIZER COMPOSITIONS COMPRSING A MONOMERIC DIHYDROPYRIDINE DERIVATIVE AND THEIR USE AKZO NOBEL N.V. (US) 2002-01-24 WO disclosed
CN-1308625-A Naphtho [2, 3-B ] heteroar-4-yl derivatives AMERICAN HOME PROD (US) 2001-08-15 CN disclosed
EP-1084458-A1 PROCESS FOR MAKING PARTICULATE COMPOSITIONS Avecia Limited (GB) 2001-03-21 EP disclosed
US-6187485-B1 FORMING PHOTOSENSITIVE RESIN LAYER COMPRISING ALKALI-INSOLUBLE RESIN AND NEGATIVE-WORKING PHOTOSENSITIVE RESIN ON SUBSTRATE; EXPOSING THROUGH PHOTOMASK; DEVELOPING EXPOSED PHOTOSENSITIVE RESIN LAYER AND CURING TO FORM CONCAVE AND CONVEX PATTERN DAI NIPPON PRINTING CO., LTD. (JP) 2001-02-13 US disclosed
EP-0979438-A1 PROCESS FOR MAKING PARTICULATE COMPOSITIONS Avecia Limited (GB) 2000-02-16 EP disclosed
US-5998073-A POLYOL RESIN HAVING A POLYOXY ALKYLENE MOIETY IN A MAIN CHAIN THEREOF, SERVING AS A BINDER RESIN, PREPARED FROM AN EPOXY RESIN, A DIHYDRIC PHENOL, AND AN ALKYLENE OXIDE ADDUCT OF A DIHYDRIC PHENOL, OR A GLYCIDYL ETHER THEREOF RICOH COMPANY, LTD. (JP) 1999-12-07 US disclosed
WO-1999050714-A1 PROCESS FOR MAKING PARTICULATE COMPOSITIONS AVECIA LIMITED (GB) 1999-10-07 WO disclosed
EP-0921440-A1 METHODS OF FORMING RAISED AND RECESSED PATTERNS AND USE OF THE PATTERNS IN THE MANUFACTURE OF LIQUID CRYSTAL DISPLAY COLOR FILTERS DAI NIPPON PRINTING CO., LTD. (JP) 1999-06-09 EP disclosed
WO-1998050828-A1 PROCESS FOR MAKING PARTICULATE COMPOSITIONS AVECIA LIMITED (GB) 1998-11-12 WO disclosed
US-5753652-A Antiretroviral hydrazine derivatives NOVARTIS CORPORATION (US) 1998-05-19 US disclosed
CN-1178031-A Black matrix in colour picture tubes and method of producing the black matrix SAMSUNG DISPLAY DEVICES CO LTD (KR) 1998-04-01 CN disclosed
EP-0521827-B1 Pharmacological active hydrazin derivatives and process for their preparation CIBA GEIGY AG (CH) 1996-09-25 EP disclosed
EP-0521474-B1 Colour-developing composition for pressure-sensitive copying paper MITSUI TOATSU CHEMICALS (JP) 1995-03-22 EP disclosed
CN-1027065-C Tetralin esters of phenols or benzoic acids ALLERGAN INC (US) 1994-12-21 CN disclosed
EP-0309262-B1 Novel salicylates, their salts, pharmaceutical compositions containing them and process for preparing same RICHTER GEDEON VEGYESZET (HU) 1994-02-02 EP disclosed
US-5260403-A Color-developing composition, aqueous suspension of the composition, and color-developing sheet produced using the suspension and suitable for use in pressure-sensitive copying paper MITSUI TOATSU CHEMICALS, INC. (JP) 1993-11-09 US disclosed
EP-0540729-A1 BLOCKED FILTER DYES FOR PHOTOGRAPHIC MATERIAL AND PROCESS EASTMAN KODAK COMPANY (US) 1993-05-12 EP disclosed
EP-0521827-A1 Pharmacological active hydrazin derivatives and process for their preparation CIBA-GEIGY AG (CH) 1993-01-07 EP disclosed
EP-0521474-A1 Colour-developing composition for pressure-sensitive copying paper MITSUI TOATSU CHEMICALS, Inc. (JP) 1993-01-07 EP disclosed
EP-0303443-B1 MULTIVALENT METAL-MODIFIED SALICYLIC ACID RESINS, AND COLOR-DEVELOPING AGENTS AND COPYING PAPER USING THE RESINS MITSUI TOATSU CHEMICALS, Inc. (JP) 1992-12-09 EP disclosed
WO-1992021064-A1 BLOCKED FILTER DYES FOR PHOTOGRAPHIC MATERIAL AND PROCESS EASTMAN KODAK COMPANY (US) 1992-11-26 WO disclosed
US-4952648-A Production process of multivalent metal-modified salicylic acid/styrene resin, color-developing agent using the resin and suited for use in pressure-sensitive copying paper sheet and pressure-sensitive copying paper unit employing the agent MITSUI TOATSU CHEMICALS, INCORPORATED (JP) 1990-08-28 US disclosed
CN-1038092-A The preparation method of the tetraline ester of phenol or benzoic acids ALLERGAN INC (US) 1989-12-20 CN disclosed
US-4879404-A Novel salicylates, their salts, pharmaceutical compositions containing them and process for preparing same RICHTER GEDEON VEGYESZETI GYAR RT (HU) 1989-11-07 US disclosed
EP-0309262-A2 Novel salicylates, their salts, pharmaceutical compositions containing them and process for preparing same RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) 1989-03-29 EP disclosed
EP-0303443-A2 Multivalent metal-modified salicylic acid resins, and color-developing agents and copying paper using the resins MITSUI TOATSU CHEMICALS, Inc. (JP) 1989-02-15 EP disclosed
EP-0080271-A1 Indomethacin phenyl ester derivatives, their use, and compositions containing them TEIKOKU KAGAKU SANGYO K.K. (JP) 1983-06-01 EP disclosed
US-4206064-A Negatively charged toner for developing electrostatic images containing metal complex of salicyclic acid compound as charge control agent CANON KABUSHIKI KAISHA (JP) 1980-06-03 US disclosed
US-4136165-A SUNSCREEN AGENTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1979-01-23 US disclosed
US-4136165-A SUNSCREEN AGENTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1979-01-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (49 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210177794-A1 FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS CPT1A, NR1H3, NR1H2 LMNA 2532/4885TSHR 2380/4885HPGD 583/4885
US-20210179533-A1 SALICYL FUMARATE DERIVATIVE AND ITS APPLICATION IN THE TREATMENT OF PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES FH, SUCNR1, SDHB LMNA 3919/4885TSHR 3480/4885HPGD 203/4885
US-20090062322-A1 Novel Tricyclic Spiropiperidines or Spiropyrrolidines REN, TACR1, AGTR1 LMNA 1499/4885TSHR 68/4885HPGD 2996/4885
US-11058698-B2 Acylated active agents and methods of their use for the treatment of autoimmune disorders ENPP2, MBOAT7, AADAC LMNA 3473/4885TSHR 2689/4885HPGD 818/4885
US-20130281520-A1 Anti-Inflammatory And Antioxidant Conjugates Useful For Treating Metabolic Disorders HSD17B14, SORD, GPX4 LMNA 3674/4885TSHR 2627/4885HPGD 45/4885
US-20100234452-A1 Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders HSD17B14, SORD, GPX4 LMNA 3674/4885TSHR 2627/4885HPGD 45/4885
US-11813272-B2 Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease FABP1, PYGL, LIPC LMNA 1035/4885TSHR 1874/4885HPGD 312/4885
US-10555892-B1 Functionalized siloxane or polysiloxane coated particles with enhanced light filtering properties SPIN4, RPS4X, RPS4Y1 LMNA 2841/4885TSHR 3254/4885HPGD 4771/4885
US-20240156769-A1 FATTY ACID DERIVATIVES FOR TREATING NON-ALCOHOLIC STEATOHEPATITIS CPT1A, NR1H2, NR1H3 LMNA 2374/4885TSHR 2467/4885HPGD 605/4885
US-12600116-B2 Special polymer layers for faster laminability of multilayer structures ASH2L, SMC2, ELL LMNA 65/4885TSHR 4367/4885HPGD 4856/4885
US-20030199569-A1 Pyrrolidine derivatives PREP, PEPD, MMP3 LMNA 4696/4885TSHR 3431/4885HPGD 105/4885
US-20110098257-A1 DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID CBS, SI, APC LMNA 4653/4885TSHR 4449/4885HPGD 161/4885
US-20240180941-A1 ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE FABP1, PYGL, LIPC LMNA 1035/4885TSHR 1874/4885HPGD 312/4885
US-10202331-B2 Antifibrinolytic compounds F2, FGB, SERPINC1 LMNA 607/4885TSHR 1732/4885HPGD 1936/4885
US-20050130941-A1 Methods of treating alzheimer's disease BACE1, PSEN1, BACE2 LMNA 1225/4885TSHR 2585/4885HPGD 554/4885
US-20050245741-A1 Novel tricyclic spiropiperidines or spiropyrrolidines REN, TACR1, AGTR1 LMNA 1862/4885TSHR 47/4885HPGD 2978/4885
US-20210283157-A1 ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS ENPP2, MBOAT7, AADAC LMNA 3473/4885TSHR 2689/4885HPGD 818/4885
US-20130102463-A1 Herbicidal Compositions PPOX, PAOX, DDT LMNA 4349/4885TSHR 2587/4885HPGD 457/4885
US-11976083-B2 Inhibitors of peptidylarginine deiminases PADI4, PADI2, PADI1 LMNA 2684/4885TSHR 1815/4885HPGD 729/4885
US-20130225463-A1 QUATERNIZED POLYETHER AMINES AND THEIR USE AS ADDITIVE FOR FUELS AND LUBRICANTS RAD54L, PUF60, UBE2L3 LMNA 2218/4885TSHR 4107/4885HPGD 2958/4885
US-20110144371-A1 PROCESS FOR PURIFYING DIALKYL CARBONATES ADH1C, AGL, DCLK3 LMNA 2175/4885TSHR 2930/4885HPGD 1952/4885
US-20130267726-A1 Thiocarbonates as Anti-Inflammatory and Antioxidant Compounds Useful For Treating Metabolic Disorders CPT1B, LTC4S, TXNRD2 LMNA 521/4885TSHR 2146/4885HPGD 881/4885
US-20080207564-A1 Derivaitves of 4-Or 5-Aminosalicylic Acid CBS, SI, TST LMNA 4721/4885TSHR 4651/4885HPGD 196/4885
US-20090233886-A1 DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID CBS, SI, APC LMNA 4653/4885TSHR 4449/4885HPGD 161/4885
US-20220110960-A1 ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS ENPP2, MBOAT7, AADAC LMNA 3473/4885TSHR 2689/4885HPGD 818/4885
US-20110130368-A1 DERIVATIVES OF 4- OR 5-AMINOSALICYLIC ACID CBS, SI, APC LMNA 4653/4885TSHR 4449/4885HPGD 161/4885
US-20170334834-A1 ANTIFIBRINOLYTIC COMPOUNDS F2, SERPINC1, F12 LMNA 1097/4885TSHR 3591/4885HPGD 306/4885
US-20120149769-A1 Thiocarbonates as Anti-Inflammatory and Antioxidant Compounds Useful For Treating Metabolic Disorders CPT1B, LTC4S, TXNRD2 LMNA 521/4885TSHR 2146/4885HPGD 881/4885
US-20110288057-A1 SALICYLIC ACID DERIVATIVES BEING FARNESYL PYROPHOSPHATE SYNTHASE ACTIVITY INHIBITORS FDPS, GGPS1, COASY LMNA 3193/4885TSHR 4174/4885HPGD 135/4885
US-20200101030-A1 MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME SI, FABP2, CEL LMNA 1830/4885TSHR 4527/4885HPGD 1813/4885
US-20020040146-A1 Pyrrolidine derivatives PREP, PEPD, MMP3 LMNA 4696/4885TSHR 3431/4885HPGD 105/4885
US-20200188418-A1 ACYLATED ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF AUTOIMMUNE DISORDERS ENPP2, MBOAT7, AADAC LMNA 3473/4885TSHR 2689/4885HPGD 818/4885
US-20130046013-A1 SALICYLATE FATTY ACID DERIVATIVES FASN, SCD, FABP2 LMNA 2520/4885TSHR 2487/4885HPGD 250/4885
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES PADI4, PADI2, PADI1 LMNA 2684/4885TSHR 1815/4885HPGD 729/4885
US-20230293458-A1 MULTIBIOTIC AGENTS AND METHODS OF USING THE SAME SI, FABP2, CEL LMNA 1830/4885TSHR 4527/4885HPGD 1813/4885
US-20200039921-A1 ANTIFIBRINOLYTIC COMPOUNDS F2, SERPINC1, F12 LMNA 1097/4885TSHR 3591/4885HPGD 306/4885
US-20200048182-A1 A SALICYL FUMARATE DERIVATIVE AND ITS APPLICATION IN THE TREATMENT OF PARKINSON'S DISEASE AND OTHER NEURODEGENERATIVE DISEASES FH, SUCNR1, SDHB LMNA 3665/4885TSHR 3371/4885HPGD 197/4885
US-12115178-B2 Acylated active agents and methods of their use for the treatment of autoimmune disorders ENPP2, MBOAT7, AADAC LMNA 3473/4885TSHR 2689/4885HPGD 818/4885
US-20200197428-A1 ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE FABP1, PYGL, LIPC LMNA 1035/4885TSHR 1874/4885HPGD 312/4885
US-20210177877-A1 ACTIVE AGENTS AND METHODS OF THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS AND NONALCOHOLIC FATTY LIVER DISEASE FABP1, PYGL, LIPC LMNA 1035/4885TSHR 1874/4885HPGD 312/4885
US-12440466-B2 Fatty acid derivatives for treating non-alcoholic steatohepatitis CPT1A, NR1H2, NR1H3 LMNA 2374/4885TSHR 2467/4885HPGD 605/4885
US-10953027-B2 Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease FABP1, PYGL, LIPC LMNA 1035/4885TSHR 1874/4885HPGD 312/4885
US-20140061533-A1 INDANE BISPHENOLS, POLYMERS DERIVED THEREFROM, AND METHODS OF USE THEREOF PGRMC1, PBRM1, PGRMC2 LMNA 1810/4885TSHR 4097/4885HPGD 250/4885
US-20150025006-A1 Pharmaceutical Combinations Including Anti-Inflammatory and Antioxidant Conjugates Useful for Treating Metabolic Disorders IAPP, AMY2A, GPR119 LMNA 4476/4885TSHR 1945/4885HPGD 552/4885
US-20040242672-A1 Useful as inhibitors of metalloproteases, e.g. zinc proteases; effective in treating disease states associated with vasoconstriction such as high blood pressure, coronary disorders, cardiac insufficiency, renal and myocardial ischaemia, renal insufficiency, dialysis, cerebral ischaemia MMP1, PEPD, MMP25 LMNA 4507/4885TSHR 4175/4885HPGD 151/4885
US-20140296580-A1 INDANE BISPHENOLS, POLYMERS DERIVED THEREFROM, AND METHODS OF USE THEREOF PGRMC1, PBRM1, PGRMC2 LMNA 1810/4885TSHR 4097/4885HPGD 250/4885
US-11925614-B2 Fatty acid derivatives for treating non-alcoholic steatohepatitis CPT1A, NR1H3, NR1H2 LMNA 2532/4885TSHR 2380/4885HPGD 583/4885
US-20070197479-A1 Derivatives of 4- or 5-aminosalicylic acid CBS, SI, APC LMNA 4653/4885TSHR 4449/4885HPGD 161/4885
US-20020052323-A1 Quinoline-(C=O)-(multiple amino acids)-leaving group compounds for pharmaceutical compositions and reagents CASP3, CASP1, BAX LMNA 45/4885TSHR 4047/4885HPGD 4599/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.